Heme Oxygenase Inhibition by α-(1H-Imidazol-1-yl)-ω-phenylalkanes: Effect of Introduction of Heteroatoms in the Alkyl Linker

ChemMedChem

Volumn 7, Issue 5, 2012, Pages 897-902

  Vlahakis, Jason Z ^a   Lazar, Carmen ^a   Roman, Gheorghe ^a   Vukomanovic, Dragic ^a   Nakatsu, Kanji ^a   Szarek, Walter A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Carbon monoxide; Heme; Heme oxygenases; Imidazoles; Inhibitors

Indexed keywords

1 (N BENZYLAMINO) 3 (1H IMIDAZOL 1 YL)PROPANE DIHYDROCHLORIDE; ALPHA (1H IMIDAZOL 1 YL) OMEGA PHENYLALKANE; CARBON; HEME OXYGENASE 1; HEME OXYGENASE 2; HEME OXYGENASE INHIBITOR; SULFUR; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; PRIORITY JOURNAL;

ALKANES; ANIMALS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; IMIDAZOLES; INHIBITORY CONCENTRATION 50; MICROSOMES; MOLECULAR STRUCTURE; OXYGEN; PHENOL; RATS; SULFUR;

EID: 84860320660     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201100602     Document Type: Article

References (22)

1. L. E. Otterbein, B. S. Zuckerbraun, Heme Oxygenase-The Elegant Orchestration of its Products in Medicine, Nova Science Publishers Inc., New York, 2005.
2. R. T. Kinobe, R. A. Dercho, K. Nakatsu, Can. J. Physiol. Pharmacol. 2008, 86, 577-599.
3. M. A. Alaoui-Jamali, T. A. Bismar, A. Gupta, W. A. Szarek, J. Su, W. Song, Y. Xu, B. Xu, G. Liu, J. Z. Vlahakis, G. Roman, J. Jiao, H. M. Schipper, Cancer Res. 2009, 69, 8017-8024.
4. M. D. Maines, FASEB J. 1988, 2, 2557-2568.
5. R. J. Wong, V. K. Bhutani, H. J. Vreman, D. K. Stevenson, NeoReviews 2007, 8, e77-e84.
6. R. J. Wong, H. J. Vreman, S. Schulz, F. S. Kalish, N. W. Pierce, D. K. Stevenson, J. Perinatol. 2011, 31, S35-S41.
7. P. Reddy, S. Najundaswamy, R. Mehta, A. Petrova, T. Hegyi, J. Perinatol. 2003, 23, 507-508.
8. A. Takeda, Y. Itoyama, T. Kimpara, X. Zhu, J. Avila, B. E. Dwyer, G. Perry, M. A. Smith, Antioxid. Redox Signaling 2004, 6, 888-894.
9. S. K. Sahoo, T. Sawa, J. Fang, S. Tanaka, Y. Miyamoto, T. Akaike, H. Maeda, Bioconjugate Chem. 2002, 13, 1031-1038.
10. H. Was, J. Dulak, A. Jozkowicz, Curr. Drug Targets 2010, 11, 1551-1570.
11. L. M. Furci, P. Lopes, S. Eakanunkul, S. Zhong, A. D. MacKerell, A. Wilks, J. Med. Chem. 2007, 50, 3804-3813.
12. J. Z. Vlahakis, R. T. Kinobe, R. J. Bowers, J. F. Brien, K. Nakatsu, W. A. Szarek, Bioorg. Med. Chem. Lett. 2005, 15, 1457-1461.
13. J. Z. Vlahakis, R. T. Kinobe, R. J. Bowers, J. F. Brien, K. Nakatsu, W. A. Szarek, J. Med. Chem. 2006, 49, 4437-4441.
14. G. Roman, J. G. Riley, J. Z. Vlahakis, R. T. Kinobe, J. F. Brien, K. Nakatsu, W. A. Szarek, Bioorg. Med. Chem. 2007, 15, 3225-3234.
15. J. Z. Vlahakis, M. Hum, M. N. Rahman, Z. Jia, K. Nakatsu, W. A. Szarek, Bioorg. Med. Chem. 2009, 17, 2461-2475.
16. G. Roman, M. N. Rahman, D. Vukomanovic, Z. Jia, K. Nakatsu, W. A. Szarek, Chem. Biol. Drug Des. 2010, 75, 68-90.
17. F. Gasparrini, M. Giovannoli, D. Misiti, J. Org. Chem. 1990, 55, 1323-1328.
18. Y.-P. Pang, F. Hong, P. Quiram, T. Jelacic, S. Brimijoin, J. Chem. Soc. Perkin Trans. 1 1997, 171-176.
19. H. E. Gottlieb, V. Kotlyar, A. Nudelman, J. Org. Chem. 1997, 62, 7512-7515.
20. H. J. Vreman, D. K. Stevenson, Anal. Biochem. 1988, 168, 31-38.
21. M. N. Cook, K. Nakatsu, G. S. Marks, B. E. McLaughlin, H. J. Vreman, D. K. Stevenson, Can. J. Physiol. Pharmacol. 1995, 73, 515-518.
22. S. D. Appleton, M. L. Chretien, B. E. McLaughlin, H. J. Vreman, D. K. Stevenson, J. F. Brien, K. Nakatsu, D. H. Maurice, G. S. Marks, Drug Metab. Dispos. 1999, 27, 1214-1219.